MedPath

To Study the Effect of Karnapurana in the Patient of Tinnitus

Phase 2/3
Recruiting
Conditions
Noise effects on inner ear. Ayurveda Condition: KARNA-NADAH,
Registration Number
CTRI/2025/04/085979
Lead Sponsor
Parul Institute Of Ayurveda And Research
Brief Summary

This study aims to compare the therapeutic effects of Karnapurana with Lashun Siddha Moorchit Sarshap Tail and Moorchit Sarshap Tail in the treatment of Karnanada (tinnitus). It is a randomized controlled trial involving adults with moderate to severe subjective tinnitus. The primary outcome will be the reduction in tinnitus severity, assessed using the Tinnitus Handicap Inventory (THI) and Tinnitus Functional Index (TFI). Secondary outcomes include quality of life, sleep quality, anxiety and depression levels, and safety monitoring. Follow-up evaluations will assess both the efficacy and safety of the treatments.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Adults aged 18-75 years.
  • Clinical diagnosis of subjective tinnitus.
  • Participants with moderate to severe tinnitus as assessed by a validated tinnitus severity scale (Tinnitus Handicap Inventory, Tinnitus Functional Index).
  • Stable general health with no acute systemic illness or active ear infections.
  • Absence of prior ear surgery or invasive procedures affecting auditory function.
  • Absence of known allergy to garlic or mustard to ensure safety of oil application.
  • Willing and able to comply with study procedures and follow-up visits.
Exclusion Criteria
  • Objective tinnitus or structural auditory abnormalities.
  • Severe otological or neurological disorders.
  • Significant psychiatric disorders.
  • Pregnancy or lactation.
  • Ear infections or inflammation.
  • Allergies to intervention.
  • Tinnitus from earwax, foreign bodies, or tympanic membrane rupture.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduces the severity of tinnitus.0-15 days | BT-0th Day | DT-7th Day | AT-15th Day
Secondary Outcome Measures
NameTimeMethod
Improvement in Tinnitus Severity (Subjective Perception),Quality of Life,Changes in Sleep Quality,Reduction in Anxiety and Depression Symptoms,Etc.0-15 days

Trial Locations

Locations (1)

KHEMDAS HOSPITAL

🇮🇳

Vadodara, GUJARAT, India

KHEMDAS HOSPITAL
🇮🇳Vadodara, GUJARAT, India
Dr Harshal Patil
Principal investigator
7020555354
dr.harshalgurjar@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.